BSE filing, NSE: GLAXO. Summary written from the filing by ALFA Finder's alert engine.
GlaxoSmithKline Pharmaceuticals Ltd: key numbers
- Share price
- ₹2,531.40
- Market cap
- ₹42,883 Cr
- Revenue (annual)
- ₹3,822 Cr
- Net profit (annual)
- ₹1,036 Cr
- P/E (TTM)
- 40.1×Sector 47.2×
- Promoter holding
- 75.00%+0.00% QoQ
- FII holding
- 4.75%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from GlaxoSmithKline Pharmaceuticals Ltd
All →GlaxoSmithKline Pharmaceuticals Board Meeting Date
GlaxoSmithKline Pharmaceuticals Limited will hold a board meeting on 3rd November 2026 to consider and approve its unaudited financial results for the quarter ended 30th September 2026.
GlaxoSmithKline Pharmaceuticals Other Announcement
GlaxoSmithKline Pharmaceuticals Ltd has filed its quarterly shareholding pattern for the quarter ended September 30, 2026, as required by SEBI listing regulations.
GlaxoSmithKline Pharmaceuticals Annual General Meeting
GSK Pharma's postal ballot approved Ms. Natland as NED and Mr. Akshikar's MD re-appointment. Both resolutions cleared with over 99% shareholder support.
GlaxoSmithKline Pharmaceuticals Annual General Meeting
GlaxoSmithKline Pharmaceuticals issued a corrigendum for its August 3, 2026, postal ballot notice, correcting a typographical error in a reported salary figure.
GlaxoSmithKline Pharmaceuticals Price Movement Clarification
GlaxoSmithKline Pharmaceuticals clarified that recent trading volume increases are purely market-driven. The company confirmed all material disclosures have been made according to SEBI regulations.
GlaxoSmithKline Pharmaceuticals Business Update
GlaxoSmithKline Pharmaceuticals received an income tax refund intimation of Rs 4.99 Crore for the assessment year 2025-2026.
- Value
- ₹4.99 Cr
Other management change announcements
All →McNally Bharat Engineering Company Management Change
McNally Bharat Engineering appointed Pradumn Kumar Dixit as Additional Non-Executive Non-Independent Director by circular resolution on 2 November 2026. Shareholder approval is needed within three months.
Fractal Analytics Management Change
Fractal Analytics reported senior management retirements: Rasesh Shah effective November 2, 2026, and Biju Dominic effective November 13, 2026. No financial impact is stated.
Walchandnagar Industries Management Change
Walchandnagar Industries appointed Chandra Bhan Yadav as Interim Chief Financial Officer and KMP effective November 2, 2026. The board also amended its fair disclosure policy.
KEC International Management Change
KEC International appointed Mr. Anant Vardhan Goenka as Additional Director (Non-Executive, Non-Independent) effective November 2, 2026. Shareholder approval is required within three months.
EPack Prefab Technologies Management Change
EPack Prefab appointed Ms. Khushboo Mishra as Company Secretary and Compliance Officer, effective 2 November 2026. She has over 13 years of experience in corporate governance and capital markets.
Transwarranty Finance Management Change
Transwarranty Finance appointed Sujit Nair as Senior Vice President - Growth and Strategic Initiatives, effective 2 November 2026. He brings over 24 years of banking and fintech experience.